NEW MILTON, United Kingdom & BOSTON--(BUSINESS WIRE)--Genetix Group plc (AIM:GTX), the cancer diagnostic and biotherapeutic technologies group (www.genetix.com), announces the introduction of CytoGenetix reagents for fluorescent in situ hybridization (FISH).
